UnitedHealth Group Incorporated (UNH) Position Raised by DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 479,837 shares of the healthcare conglomerate’s stock after purchasing an additional 23,342 shares during the quarter. UnitedHealth Group comprises about 0.7% of DekaBank Deutsche Girozentrale’s investment portfolio, making the stock its 29th largest holding. DekaBank Deutsche Girozentrale’s holdings in UnitedHealth Group were worth $89,532,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. First Trust Advisors LP increased its holdings in UnitedHealth Group by 7.5% in the second quarter. First Trust Advisors LP now owns 327,481 shares of the healthcare conglomerate’s stock valued at $60,722,000 after purchasing an additional 22,800 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its stake in UnitedHealth Group by 1.1% in the second quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 301,700 shares of the healthcare conglomerate’s stock valued at $55,941,000 after acquiring an additional 3,362 shares during the period. New Jersey Better Educational Savings Trust acquired a new position in UnitedHealth Group in the second quarter valued at about $556,000. Schwab Charles Investment Management Inc. grew its stake in UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after acquiring an additional 183,401 shares during the period. Finally, Wetherby Asset Management Inc. grew its stake in UnitedHealth Group by 2.9% in the second quarter. Wetherby Asset Management Inc. now owns 16,498 shares of the healthcare conglomerate’s stock valued at $3,060,000 after acquiring an additional 459 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Position Raised by DekaBank Deutsche Girozentrale” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/12/unitedhealth-group-incorporated-unh-position-raised-by-dekabank-deutsche-girozentrale.html.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 in the last quarter. Company insiders own 0.89% of the company’s stock.
UNH has been the subject of a number of research analyst reports. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley boosted their target price on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, June 28th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Finally, Deutsche Bank AG boosted their target price on UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, July 13th. Three analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $203.59.
UnitedHealth Group Incorporated (UNH) opened at 195.26 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $133.03 and a 12 month high of $200.76. The company’s 50-day moving average price is $196.60 and its 200 day moving average price is $184.31. The firm has a market capitalization of $188.79 billion, a PE ratio of 23.46 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.96 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.